Neovascularization of Ischemic Myocardium

Neovascularization  launched by vascular endothelial development factor (VEGF) addresses an attractive methodology for the treatment of ischemic coronary disease. However, VEGF treatment has been linked to transient impacts and it is likely to develop hemangioma. The Fundamental Mesenchymal Mesenchymal (MSC) microorganisms of adults were obtained from the bone marrow is a promising access point for the recovery and solution of the tissues. To obtain an angiogenic protected and tenacious impact, we have studied autologous MSC transplant capacity to improve angiogenesis and cardiovascular capacity of ischemic hearts. Multi week after the localized myocardial necrosis started by the impairment of the left front sinking course, the extended autologists of the vitro were administered intramario in the infarct space of a similar payer. In 2 months, MSCS implementation levels are fundamentally increased, they joined the expanded vascular thickness and territorial blood flow in the heart attack. area

Author(s): Edina Garai

Abstract | PDF

Share This Article